NEW YORK – Novacyt said on Monday that its molecular test for the COVID-19 virus has received CE marking.
The company's molecular division, Primerdesign, has launched the test, which follows the launch of Novacyt's research-use-only coronavirus test on Jan. 31. Laboratories and hospitals can use the clinical test on patients without the need for validation by clinicians, according to Paris-based Novacyt.